XML 13 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
Revenues   $ 1,000,000
Operating expenses:    
Research, development and patents $ 7,194,731 5,657,895
General and administrative 5,480,600 5,242,370
Total operating expenses 12,675,331 10,900,265
Operating loss (12,675,331) (9,900,265)
Interest income 1,670,804 1,834,665
Other expense, net (39,485) (502,869)
Loss before income taxes (11,044,012) (8,568,469)
Income tax expense (5,537) (3,047)
Net loss $ (11,049,549) $ (8,571,516)
Basic net loss per common share $ (0.23) $ (0.17)
Diluted net loss per common share $ (0.23) $ (0.17)
Shares used to compute basic net loss per common share 49,046,246 49,046,246
Shares used to compute diluted net loss per common share 49,046,246 49,046,246
Net loss $ (11,049,549) $ (8,571,516)
Other comprehensive loss, net of tax:    
Foreign currency translation adjustments (17,064) (2,805)
Comprehensive loss $ (11,066,613) $ (8,574,321)